Clinical Trials
36
Active:1
Completed:13
Trial Phases
4 Phases
Phase 1:1
Phase 2:10
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Not Applicable
18 (58.1%)Phase 2
10 (32.3%)Phase 4
2 (6.5%)Phase 1
1 (3.2%)MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer
Phase 2
Not yet recruiting
- Conditions
- Cutaneous Squamous Cell Carcinoma (CSCC)
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- University of Vermont Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT06998342
- Locations
- 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States
Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial
Phase 2
Not yet recruiting
- Conditions
- Brain Metastases, AdultBrain Metastases From Non-small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- University of Vermont Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT06974370
- Locations
- 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States
Optimizing Aerobic Fitness in Older Adults
Not Applicable
Recruiting
- Conditions
- Aerobic CapacityHigh Intensity Interval Training
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- University of Vermont Medical Center
- Target Recruit Count
- 114
- Registration Number
- NCT06951620
- Locations
- 🇺🇸
UVMMC Cardiac Rehabilitation, South Burlington, Vermont, United States
Avocado and Postprandial Responses
Not Applicable
Recruiting
- Conditions
- Healthy VolunteerHealthy Male and Female SubjectsHealthy Volunteers OnlyHealthy VolunteersHealthy AdultHealthy SubjectsHealthy Non-smokersHealthy
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- University of Vermont Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT06818032
- Locations
- 🇺🇸
Clinical Research Center, University of Vermont Medical Center, Burlington, Vermont, United States
Hybrid Arc Palliative Radiation Therapy (HART): a Single Arm Phase II Trial
Phase 2
Not yet recruiting
- Conditions
- Palliative RadiotherapyMetastatic Cancer (different Solid Tumour Types)
- First Posted Date
- 2025-01-16
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- University of Vermont Medical Center
- Target Recruit Count
- 103
- Registration Number
- NCT06778408
- Locations
- 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
No news found